Status:
UNKNOWN
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
Lead Sponsor:
Lei Li
Conditions:
Colorectal Neoplasms, Hereditary Nonpolyposis
Endometrial Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
In patients diagnosed as endometrial cancer by thorough pathologic examinations, Lynch syndromes are screened by (1)immunohistochemical staining (for MLH1, MSH2, MSH6 and PMS2), (2) tests of microsate...
Eligibility Criteria
Inclusion
- Survivals of endometrial cancer
Exclusion
- Metatatic malignacies to uterine
- Leiomyosarcoma of uterus
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03291106
Start Date
September 1 2017
End Date
October 1 2020
Last Update
November 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, China/Beiing, China, 100000